Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Kuwait

Hikma Announces Strong Sales

April 2006 | Company Finance Alert

Jordanian drugmaker Hikma has announced sales of US$262mn in 2005, an increase of 23.5% compared to the same period last year. Meanwhile profits reached US$135.8mn, up 25.2%. This strong performance has been driven primarily by the performance of Hikma's generics business, which rose 8.5% to reach US$115.2mn. However, 2005 saw a significant rise in sales for branded drugs, which reached US$93mn, up

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Hikma On Upward Track

Companies / Kuwait Hikma's 2007 performance is being hailed as a success by industry observers. The company's full-year results for 2007 revealed that sales were up by a massive 41.6% on 2006, to US$448mn, while pre-tax...
March 2008
Hikma Bids For Local Rival

Companies / Kuwait In a move that would ensure its dominance of the local pharmaceutical market, Jordan's largest drugmaker Hikma has launched a JOD116mn (US$164mn) bid to acquire rival Arab Pharmaceutical Manufacturing...
October 2007
Jordan Continues To Develop As A Drug Manufacturing Base

Companies / Kuwait According to recently released data, the Jordanian drug industry exported products worth JOD198.6mn (US$280mn) in 2005, which is directly in line with BMI estimates. However, BMI believes that the Jordanian...
January 2007
Dar Al Dawa Records Solid Results

Companies / Kuwait Jordanian drugmaker Dar Al Dawa (DADI) recorded sales of JOD32.84mn (US$46.26mn) in 2005, with net income reaching JOD7.71mn (US$10.87mn), an increase of 7.27% compared to the same period last year....
April 2006
Hikma To Acquire Remaining Shares In JPI

Companies / Kuwait Jordanian drugmaker Hikma has announced that it is to acquire the 52.5% of its Saudi Arabian subsidiary Al Jazeera Pharmaceuticals Industries (JPI) that it does not already own, for SAR78.75 (US$20.93mn)....
April 2006
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS